Journal of Pharmacy and Pharmacology · 1988 · 114 citations · 10 references
MedicineNeurosciencePharmacologyNeuropharmacologyPharmacodynamicsPsychopharmacologyLigand BindingNeurotransmissionNeurotransmitter ReceptorsReceptor BindingReceptor PharmacologyReceptor-ligand Interactions5-Hydroxytryptamine 3 Receptor Antagonists5-Hydroxytryptamine Receptor PharmacologyReceptor-ligand SelectivitySaturable BindingScatchard AnalysisSerotonin Receptor BindingSerotonin Receptor PharmacologySerotonin Receptor Subtypes
[3H]Zacopride displayed saturable binding to homogenates of the rat entorhinal cortex as measured by the inclusion of the 5-HT3 receptor antagonist BRL43694 in the incubation media. Scatchard analysis indicated a single high affinity binding site (KD 0.76 +/- 0.08 nM, Bmax 77.5 +/- 6.5 fmol (mg protein)-1) with a Hill slope close to unity. Other 5-HT3 receptor antagonists (zacopride, ICS 205-930, GR38032F, GR65630, metoclopramide and cocaine) also competed for the binding site displacing 60% of the total [3H]zacopride binding. 5-HT and 2-methyl-5-HT also were competitive antagonists for [3H]zacopride binding whereas 5-HT1/5-HT2 agonists and antagonists, and agents acting on other neurotransmitter receptors had Ki values greater than 10(-5) M. It is concluded that [3H]zacopride may prove a useful ligand for the study of 5-HT3 recognition sites.
10
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Philip Bradley, G. Engel, W. Feniuk et al. · Neuropharmacology · 1986 · 1.3K citations
Medicine, Neuroscience, Pharmacology +12
John R. Fozard · Trends in Pharmacological Sciences · 1987 · 167 citations